These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28203470)

  • 1. Unusual Presentation of Type 1 Idiopathic Macular Telangiectasia.
    Bentaleb Machkour Z; Denis P; Kodjikian L
    Case Rep Ophthalmol Med; 2017; 2017():5395069. PubMed ID: 28203470
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 1 idiopathic macular telangiectasia associated with type 3 neovascularization.
    Tilleul J; Querques G; Capuano V; Miere A; Srour M; Souied EH
    Case Rep Ophthalmol; 2014; 5(3):352-6. PubMed ID: 25759660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
    Matos R; Beato J; Silva M; Silva S; Brandão E; Falcão-Reis F; Penas S
    Ophthalmic Genet; 2017; 38(5):490-493. PubMed ID: 28121209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral Type 1 Idiopathic Macular Telangiectasia in a Female Patient: Multimodal Imaging of a Rare Presentation.
    Niyousha MR; Hassanpoor N; Jafari S
    Case Rep Ophthalmol; 2021; 12(2):373-379. PubMed ID: 34054487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].
    De Bats F; Denis P; Kodjikian L
    J Fr Ophtalmol; 2013 Feb; 36(2):164-71. PubMed ID: 23200165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II idiopathic macular telangiectasia and soft confluent drusen.
    Querques G; Coscas G; Soubrane G; Souied EH
    Eur J Ophthalmol; 2010; 20(2):466-8. PubMed ID: 19967665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coats' Disease Diagnosed During Adulthood.
    Mandura RA; Alqahtani AS
    Cureus; 2021 Jul; 13(7):e16303. PubMed ID: 34381658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual presentations of type 2 idiopathic macular telangiectasia.
    Atmani K; Querques G; Zourdani A; Benhamou N; Souied EH
    Ophthalmologica; 2013; 230(3):126-30. PubMed ID: 23969580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refining Coats' disease by ultra-widefield imaging and optical coherence tomography angiography.
    Rabiolo A; Marchese A; Sacconi R; Cicinelli MV; Grosso A; Querques L; Querques G; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1881-1890. PubMed ID: 28875282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up of an Atypical Case of Idiopathic Macular Telangiectasia.
    Mucciolo DP; Murro V; Giorgio D; Sodi A; Virgili G; Rizzo S
    Ophthalmic Surg Lasers Imaging Retina; 2018 Dec; 49(12):e278-e283. PubMed ID: 30566714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema.
    Brar M; Yuson R; Kozak I; Mojana F; Cheng L; Bartsch DU; Oster SF; Freeman WR
    Retina; 2010 Mar; 30(3):383-9. PubMed ID: 20216291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II Macular Telangiectasia Presenting as Bilateral Retinochoroidal Anastomosis.
    Agarwal A; Invernizzi A; Kumari N; Singh R
    Optom Vis Sci; 2016 Oct; 93(10):1292-1295. PubMed ID: 27668494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLINICAL FEATURES OF TREATED AND UNTREATED TYPE 1 IDIOPATHIC MACULAR TELANGIECTASIA WITHOUT THE OCCURRENCE OF SECONDARY CHOROIDAL NEOVASCULARIZATION FOLLOWED FOR 2 YEARS IN JAPANESE PATIENTS.
    Osaka R; Shiragami C; Ono A; Kobayashi M; Takasago Y; Yamashita A; Tsujikawa A
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S114-S122. PubMed ID: 28541960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.
    Veloso CE; Vianna RN; Pelayes DE; Nehemy MB
    Ophthalmic Res; 2013; 49(4):205-8. PubMed ID: 23364325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
    Charbel Issa P; Holz FG; Scholl HP
    Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic macular telangiectasia - follow-up with and without laser photocoagulation].
    Stoffelns BM; Schoepfer K; Kramann C
    Klin Monbl Augenheilkd; 2010 Apr; 227(4):252-6. PubMed ID: 20408068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-Widefield Imaging of Peripheral Vascular Abnormalities in Idiopathic Macular Telangiectasia Type 1.
    Pollmann AS; Mishra AV; Francisconi CLM
    J Vitreoretin Dis; 2021; 5(6):549-552. PubMed ID: 37007172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).
    Pencak M; Krasny J; Veith M; Vokrojova M
    BMC Ophthalmol; 2016 Nov; 16(1):200. PubMed ID: 27835961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.